Objective To observe the therapeutic effects of astragalus membranaceus parenteral solution on the elders with cerebral infarction and its influences on patients' nerve function,activities of daily living and hemorheology. Methods Ninety-two patients diagnosed with cerebral infarction who were older than 60 years were randomly divided into astragalus membranaceus group(n=50) and control group (n=42). The two groups were treated with conventional therapy. But based on conventional therapy, astragalus membranaceus parenteral solution (30 mL, 2 g/mL) added into 5%glucose saline was used in the astragalus membranaceus group once daily for 4 weeks. The clinical therapeutic effects, nerve function, ability of activities of daily living and hemorheology were compared between the 2 groups. Results The total effective rate of the astragalus membranaceus group was not significantly different from that of the control group (P＞0.05), while the excellent rate and therapeutic effects of the astragalus membranaceus group was significantly higher than that of the control group (P＜0.05). Compared with control group, the scores of the neurologic impairment were decreased significantly(P＜0.05), Barthel index was increased significantly (P＜0.05), whole blood viscosity, hematocrit and fibrinogen were decreased significantly (P＜0.05) in the astragalus membranaceus group. Conclusions Astragalus membranaceus parenteral solution can improve nerve function and the ability of activities of daily living of the gerontal cerebral infarction patients.%目的 探讨黄芪注射液治疗老年脑梗死的临床疗效及对神经功能缺损、日常生活活动能力和血液流变学的影响. 方法 将92例诊断明确的年龄＞60岁的脑梗死患者按随机数字表法分为黄芪组(n=50)和对照组(n=42),两组入院后均按常规方法给予对症治疗,黄芪组加用黄芪注射液30 mL(含生药2 g/mL)加入5%葡萄糖盐水中静脉滴注,1次/d,连用4周.对两组的临床疗效、神经功能缺损程度、日常生活活动能力和血液流变学情况进行比较. 结果 黄芪组总有效率与对照组基本相当,差异无统计学意义(P＞0.05);显效率、疗效显著高于对照组(P＜0.05).与对照组比较,黄芪组神经功能缺损评分显著降低(P＜0.05),Barthel指数显著升高(P＜0.05).全血粘度、红细胞压积和纤维蛋白原下降程度较对照组显著,差异均有统计学意义(P＜0.05). 结论 黄芪注射液可改善老年脑梗死患者神经功能缺损,提高日常生活活动能力.
展开▼
